Orthofix Medical Inc.
OFIXNasdaqCIK 884624HealthcareFiscal year ends Dec 23
Reports and events: 365 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0511:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-333822 |
| 2026-08-0511:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-333817 |
| 2026-07-0220:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-294445 |
| 2026-06-1111:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-266679 |
| 2026-05-2720:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-006790 |
| 2026-05-2112:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-233429 |
| 2026-05-0511:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-205003 |
| 2026-05-0511:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-204999 |
| 2026-04-2920:20 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001193125-26-191716 |
| 2026-04-0911:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-148853 |
| 2026-02-2412:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-065189 |
| 2026-02-2412:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-065184 |
| 2026-02-1321:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-001727 |
| 2025-11-0414:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-263670 |
| 2025-11-0412:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-263529 |
| 2025-10-2120:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-015160 |
| 2025-09-2500:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-014209 |
| 2025-08-0511:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102384 |
| 2025-08-0511:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-102383 |
| 2025-06-2013:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-088194 |
| 2025-05-0822:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-001347 |
| 2025-05-0611:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063956 |
| 2025-05-0611:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-063953 |
| 2025-04-3020:13 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0000950170-25-061062 |
| 2025-04-1118:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-005766 |
| 2025-04-0720:48 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0000950170-25-051645 |
| 2025-03-1212:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-037630 |
| 2025-02-2723:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-000640 |
| 2025-02-2512:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026066 |
| 2025-02-2512:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-026062 |
| 2025-01-0721:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001214659-25-000281 |
| 2024-11-0821:35 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-124165 |
| 2024-11-0712:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122782 |
| 2024-11-0712:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122777 |
| 2024-08-0611:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091200 |
| 2024-08-0611:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-091199 |
| 2024-06-2011:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-075288 |
| 2024-05-0712:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053966 |
| 2024-05-0712:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-053961 |
| 2024-04-2920:59 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0000950170-24-050013 |
| 2024-04-2221:00 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-24-000933 |
| 2024-04-2222:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-046161 |
| 2024-04-1220:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-044082 |
| 2024-03-0521:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-025877 |
| 2024-03-0521:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-025867 |
| 2024-01-1722:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-005068 |
| 2024-01-0922:28 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-003420 |
| 2024-01-0821:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002924 |
| 2023-12-1521:14 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-070740 |
| 2023-12-1322:16 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-23-002760 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.